Browsing: dr reddy's laboratories share rating

We hosted Dr. Reddy’s Laboratories’ (DRL) in our ESG conference. The enterprise was represented by Mr Parag Agarwal (CFO), Mr…

Dr. Reddy’s Laboratories’ (DRL’s) reported Q4FY21 efficiency broadly in line with our estimates. Revenue grew 6.7% y-o-y to Rs 47.3…

Our channel checks indicate API provide constraints for generic suppliers of Vascepa. Amarin has added EU and China as new markets, thereby committing more volumes to its frequent API vendor base.